Institut Pasteur – International Course on Antibiotics and Resistance (ICARE)
Les Pensieres Annecy, FranceSpeakers include Erin Duffy, CARB-X Chief of Research and Development. The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is […]
Challenges in Antimicrobial Resistance – A Conversation with Kevin Outterson
Harvard Chan School of Public Health 677 Huntington Ave FXB 301, Boston, MA, United StatesKevin Outterson, Executive Director of CARB-X, will be speaking at the Harvard Chan School of Public Health. This presentation is sponsored by Harvard Antimicrobial Resistance (HAMR) a subgroup of the […]
World Anti-Microbial Resistance Congress 2019
Renaissance Washington DC Downtown Hotel 999 9th St NW, Washington, DC, United StatesKevin Outterson, Executive Director of CARB-X, will be giving the keynote Address on November 7th, titled "A vision for a health antibiotic R&D ecosystem". Outterson will also be participating on […]
Live Webinar: GARDP/REVIVE – Converting Gram-positive-only compounds into broad-spectrum antibiotics
Webinar 765 Commonwealth Avenue, Boston, MA, United StatesThis webinar by Paul Hergenrother (Department of Chemistry and the Institute for Genomic Biology University of Illinois, US) will detail his research group's efforts to understand compound accumulation in the […]
CRISPR and Gene Editing: The New Frontier in Fighting Infectious Diseases?
JLabs @ Toronto 661 University Ave Suite 1300, Toronto, Ontario, CanadaPresenters include Karen Gallant, Deputy Executive Director of CARB-X. Few technologies have the potential to disrupt and eliminate infectious disease and viral infections– but gene editing, CRISPR in particular, is […]
The 2019 Canada Gairdner Foundation / Ontario International Symposium: Fuelling the Fight against AMR – Global Innovations in Research & Discovery
McMaster University 1280 Main Street W, Hamilton, Ontario, CanadaKevin Outterson, Executive Director of CARB-X, is participating in a special panel discussion titled "When antibiotics fail: An international conversation about the worrisome evidence of impact and what can be […]
FDA Workshop: Enhancing the Clinical Trial Enterprise for Antibacterial Drug Development in the United States
FDA White Oak Campus - Building 31 10903 New Hampshire Ave, Silver Spring, MD, United StatesPresenters include Kevin Outterson, Executive Director of CARB-X, and Erin Duffy, CARB-X Chief of Research and Development. The FDA, IDSA, NIAID and Pew are co-sponsoring this workshop to focus on […]
Live Webinar: GARDP/REVIVE – Innovation in point-of-care diagnostics for sepsis and bloodstream infections
Webinar 765 Commonwealth Avenue, Boston, MA, United StatesIn this webinar our moderator Caroline Purslow (Nesta Challenges) will welcome three speakers. Till Bachmann (University of Edinburgh) will give an overview of recent advances in AMR diagnostics development. He […]
Exploring Opportunities to Reform Antimicrobial Payment and Post-Market Incentives
Washington Marriott at Metro Center 775 12th Street NW, Washington, DC, United StatesSpeakers include Kevin Outterson, Executive Director of CARB-X. The rise of antimicrobial resistance and the corresponding lack of novel antibiotic development impacts the ability of physicians to provide appropriate care […]
Davos 2020 World Economic Forum – Novo Nordisk Foundation and Novo Holdings: The Broken Model of Antimicrobial resistance
DAVOS-KLOSTERS , SwitzerlandModerator: Kevin Outterson, Executive Director, CARB-X, Professor of Law, Boston University Panel: Lars Rebien Sorensen, Chairman of the Novo Nordisk Foundation and Novo Holdings Jeremy Farrar, Director, Wellcome Trust Dr. Malin […]